The US Supreme Court ruled Tuesday in a 5-4 decision that the U.S. Food and Drug Administration (FDA) policy requiring patients seeking mifepristone to pick up the pill in person at a hospital, clinic, or medical office be reinstated. Three lower courts had blocked the Food and Drug Administration’s in-personContinue Reading